Unlike Rofecoxib, Celecoxib Not Linked to Increased Risk of MI

"Unlike rofecoxib, celecoxib does not appear to increase risk of myocardial infarction (MI), according to the results of a case-control study posted online Dec. 7 and published in the Feb. 1, 2005, print issue of the Annals of Internal Medicine."